Bimodal, Reciprocal Regulation of Fibroblast Growth Factor Receptor 1 Promoter Activity by BTEB1/KLF9 During Myogenesis
Overview
Molecular Biology
Authors
Affiliations
Expression of the gene encoding fibroblast growth factor receptor 1 (FGFR1) and subsequent FGFR1-mediated cell signaling controls numerous developmental and disease-related processes. The transcriptional regulation of the FGFR1 gene is central to these developmental events and serves as a molecular model for understanding transcriptional control of growth factor receptor genes. The FGFR1 promoter is activated in proliferating myoblasts via several Sp1-like binding elements. These elements display varying levels of activation potential, suggesting that unique protein-DNA complexes coordinate FGFR1 gene expression via each of these sites. The Krüppel-like factor, BTEB1/KLF9, was expressed in both proliferating myoblasts and differentiated myotubes in vitro. The BTEB1 protein was nuclear-localized in both cell types. BTEB1 activated the FGFR1 promoter via interaction with the Sp1-like binding site located at -59 bp within the FGFR1 promoter. FGFR1 gene expression is down-regulated during myogenic differentiation, and FGFR1 promoter activity is correspondingly reduced. This reduction in FGFR1 promoter activity was attributable to BTEB1 interaction with the same Sp1-like binding site located at -59 bp in the FGFR1 promoter. Therefore, BTEB1 is capable of functioning as a transcriptional activator and repressor of the same promoter via the same DNA-binding element and demonstrates a novel, bimodal role of BTEB1 during myogenesis.
Wu P, Xia S, Yu H, Zhao X, Zhang G, Wang K BMC Genomics. 2024; 25(1):1158.
PMID: 39614141 PMC: 11607835. DOI: 10.1186/s12864-024-11024-4.
Research Progress on the Regulating Factors of Muscle Fiber Heterogeneity in Livestock: A Review.
Wang Y, Zhang D, Liu Y Animals (Basel). 2024; 14(15).
PMID: 39123750 PMC: 11311112. DOI: 10.3390/ani14152225.
Simmen F, Alhallak I, Simmen R Cancers (Basel). 2023; 15(23).
PMID: 38067370 PMC: 10705314. DOI: 10.3390/cancers15235667.
Wang R, Zhong J, Pan X, Su Z, Xu Y, Zhang M J Transl Med. 2023; 21(1):840.
PMID: 37993879 PMC: 10664560. DOI: 10.1186/s12967-023-04718-y.
Ybanez W, Bagamasbad P Cancer Cell Int. 2023; 23(1):33.
PMID: 36823570 PMC: 9948451. DOI: 10.1186/s12935-023-02874-1.